title: Management of cicatricial ectropion secondary to pyoderma gangrenosum.
abstract: Pyoderma gangrenosum is a rare condition with few cases of eyelid involvement reported in the literature. Pathergy is a well-recognised phenomenon that can trigger this condition. Pyoderma gangrenosum should be considered in cases of progressive cribriform cicatrisation where there is a history of antecedent trauma. Surgical management of a resultant ectropion may be challenging as a result of aggressive scarring and the risk of provoking a recurrence. We report a case of pyoderma gangrenosum causing a cicatricial ectropion, and discuss the underlying aetiology of iatrogenic incitement, and its implications for surgical management.
authors.affiliation: Manchester Royal Eye Hospital, Oculoplastic, Lacrimal and Orbital Surgery , Manchester , United Kingdom .
authors.forename: Reshma Sreekumaran
authors.initials: RS
authors.lastname: Thampy
authors.forename: Firas
authors.initials: F
authors.lastname: Al-Niaimi
authors.forename: Calum
authors.initials: C
authors.lastname: Lyon
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Duff
authors.forename: Brian
authors.initials: B
authors.lastname: Leatherbarrow
mesh_terms: D002921:Cicatrix / Q000209:etiology / Q000628:therapy*; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use*; D004483:Ectropion / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000150:complications*; D016038:Skin Transplantation
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine